Customization: | Available |
---|---|
Application: | Internal Medicine |
Usage Mode: | For oral administration |
Still deciding? Get samples of US$ 0/Piece
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Griseofulvin is primarily indicated for dermatophytic infections, fungal infections, and Parkinson's disease.
Do not use griseofulvin in patients with porphyria, hepatocellular failure, or a history of hypersensitivity to griseofulvin.
Common adverse reactions include nausea, diarrhea, headache, skin eruptions, and photosensitivity. Rarely, hepatotoxicity and neurological side effects may occur.
Griseofulvin may interact with blood thinners and birth control pills.
Exercise caution in patients with liver disease, porphyria, lupus, alcohol abuse history, allergies, those taking other medications, during pregnancy, and breastfeeding. Avoid sunlight exposure.
Griseofulvin is pregnancy category C. Avoid use during pregnancy due to potential risks. No data on excretion into human milk.
Symptomatic and supportive treatment is recommended as there is no specific antidote for griseofulvin intoxication.
Store below 25ºC, protect from moisture, and keep out of reach of children.